|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/725 | |
| C07K 14/47 | |||
| A61P 35/00 | |||
| A61K 35/26 |
| (11) | Number of the document | 3514172 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19151238.3 |
| Date of filing the European patent application | 2015-03-30 | |
| (97) | Date of publication of the European application | 2019-07-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| PCT/EP2014/0008 | 2014-04-01 | WO | |
| PCT/EP2014/0728 | 2014-10-24 | WO |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
OEHM, Petra, DE
OMOKOKO, Tana, DE
HOFF, Holger, DE
VOSS, Ralf-Holger, DE
BREITKREUZ, Andrea, DE
HOBOHM, Kathleen, DE
MROZ, Karolina Anna, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
BioNTech Cell & Gene Therapies GmbH, An der Goldgrube 12, 55131 Mainz, DE Ganymed Pharmaceuticals GmbH, An der Goldgrube 12, 55131 Mainz, DE |
| (54) | CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES |
| CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES |